Published in J Immunol on August 01, 1998
Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest (2004) 2.57
A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J (2007) 2.44
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev (2008) 1.73
Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages. J Immunol (2010) 1.42
Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest (2004) 1.34
Integrin alpha(M)beta(2)-mediated cell migration to fibrinogen and its recognition peptides. J Exp Med (2001) 1.34
Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med (2011) 1.30
Age-related differences in plasma proteins: how plasma proteins change from neonates to adults. PLoS One (2011) 1.22
Integrin and chemokine receptor gene expression in implant-adherent cells during early osseointegration. J Mater Sci Mater Med (2009) 0.89
Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor. Hum Mol Genet (2012) 0.89
Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9. Thromb J (2010) 0.84
Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis. J Immunol (2013) 0.83
Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice. Arthritis Rheumatol (2014) 0.82
Opening the field of integrin biology to "biased agonism". Circ Res (2011) 0.82
Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. Blood (2008) 0.79
Thrombomodulin protects against lung damage created by high level of oxygen with large tidal volume mechanical ventilation in rats. J Intensive Care (2014) 0.76
Extracellular transport of cell-size particles and tumor cells by dendritic cells in culture. Exp Mol Pathol (2013) 0.75
Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection. Semin Thromb Hemost (2016) 0.75
Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse? Mediators Inflamm (2016) 0.75
The Role of Serum Fibrinogen Level in the Diagnosis of Acute Appendicitis. J Clin Diagn Res (2017) 0.75
Thrombin promotes diet-induced obesity through fibrin-driven inflammation. J Clin Invest (2017) 0.75
Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis. Arterioscler Thromb Vasc Biol (2017) 0.75
Antigens on human monocytes identified by monoclonal antibodies. J Immunol (1981) 4.67
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science (1991) 3.96
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest (1984) 3.01
Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma (1982) 2.92
Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest (1984) 2.46
Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest (1988) 2.46
Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol (1986) 2.45
Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest (1984) 2.29
Immunologic classification of leukemia and lymphoma. Blood (1986) 2.28
The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest (1994) 1.82
Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res (1994) 1.64
Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med (1985) 1.55
Analysis of antigenic determinants on human monocytes and macrophages. Blood (1982) 1.50
Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res (1997) 1.49
Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest (1993) 1.49
Conservation of myeloid surface antigens on primate granulocytes. Blood (1983) 1.44
Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol (1993) 1.44
The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest (1996) 1.38
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol (2001) 1.37
Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol (1994) 1.37
Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature (1989) 1.37
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36
Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest (1992) 1.33
Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury. J Immunol (1992) 1.30
Integrins as promiscuous signal transduction devices. Immunol Today (1996) 1.27
Surface membrane heterogeneity among human mononuclear phagocytes. J Immunol (1984) 1.27
Norms for the Mini-Mental State Examination from a sample of Sri Lankan older people. Int J Geriatr Psychiatry (2009) 1.26
Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3. J Immunol (1994) 1.25
[The effect of epidural anesthesia on tourniquet pain: a comparison of 2% lidocaine and 0.5% bupivacaine]. Ma Zui Xue Za Zhi (1990) 1.25
Urokinase receptor. An activation antigen in human T lymphocytes. J Immunol (1994) 1.24
Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. Am J Pathol (1993) 1.24
Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc Natl Acad Sci U S A (1998) 1.20
Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies. Prog Hematol (1981) 1.19
Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol (1994) 1.17
The continuing saga of complement receptor type 3 (CR3) J Clin Invest (1996) 1.15
Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation (1990) 1.15
Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol (1993) 1.14
Neutrophil-induced injury of rat pulmonary alveolar epithelial cells. J Clin Invest (1986) 1.14
Association between gelatinase release and increased plasma membrane expression of the Mo1 glycoprotein. Blood (1987) 1.14
LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion. J Immunol (1996) 1.13
Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e. J Immunol (1985) 1.13
A monoclonal antibody that blocks class II histocompatibility-related immune interactions. Hum Immunol (1984) 1.12
Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines. J Immunol (1984) 1.10
Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol (1995) 1.09
Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol (1998) 1.09
Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood (2001) 1.08
Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J Immunol (1995) 1.08
Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester. Leuk Res (1981) 1.07
Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils. J Immunol (2000) 1.07
cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol (1992) 1.06
Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mo1 monoclonal antibody. Blood (1987) 1.06
Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and superoxide production. J Immunol (1993) 1.06
Deficiency of leukocyte surface glycoproteins Mo1, LFA-1, and Leu M5 in a dog with recurrent bacterial infections: an animal model. Blood (1987) 1.05
Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes. J Leukoc Biol (1993) 1.05
Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils. Biophys J (1997) 1.04
The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen. Blood (1985) 1.04
Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization. J Immunol (1996) 1.04
Human macrophage-lymphocyte interaction in proliferation to soluble antigen. I. Specific delection of lymphocyte proliferative activity on macrophage monolayers. Cell Immunol (1980) 1.00
The role of the macrophage in in vitro primary anti-DNP antibody production in man. J Immunol (1981) 1.00
Interaction of Fc gamma receptor type IIIB with complement receptor type 3 in fibroblast transfectants: evidence from lateral diffusion and resonance energy transfer studies. J Mol Biol (1995) 0.99
Role of leukocyte adhesion molecules in lung and dermal vascular injury after thermal trauma of skin. Am J Pathol (1994) 0.99
Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Am J Physiol (1994) 0.98
Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis. J Pediatr (1991) 0.98
Surface Mo1 (CD11b/CD18) glycoprotein is up-modulated by neutrophils recruited to sites of inflammation in vivo. Inflammation (1989) 0.98
Alkaptonuric ochronosis presenting as palmoplantar pigmentation. Clin Exp Dermatol (2000) 0.97
Modulation of surface CD11/CD18 glycoproteins (Mo1, LFA-1, p150,95) by human mononuclear phagocytes. Clin Immunol Immunopathol (1988) 0.97
Deficiency of two human leukocyte surface membrane glycoproteins (Mo1 and LFA-1). Fed Proc (1985) 0.97
Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol (1995) 0.96
Human macrophage--lymphocyte interaction in proliferation to soluble antigen. II. Characterization of lymphocyte binding to antigen-pulsed macrophage monolayers. Cell Immunol (1980) 0.96
CR3 (alphaM beta2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective Fc gammaRIIA (CD32) tail-minus mutant. J Immunol (1996) 0.96
Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood (1995) 0.95
Plasminogen activation in healing human wounds. Am J Pathol (1994) 0.95
Immunological investigation of individuals with toluene diisocyanate asthma. Clin Exp Immunol (1969) 0.94
Expression of specific granule markers on the cell surface of neutrophil cytoplasts. Blood (1986) 0.94
Familial carboxypeptidase N deficiency. Ann Intern Med (1980) 0.93
Generation of antigen-specific suppressor cells in vitro in man. J Immunol (1983) 0.92
Smooth muscle hamartoma associated with bilateral becker's nevus. Indian J Dermatol Venereol Leprol (2010) 0.92
Neutrophil C3bi receptors: formation of membrane clusters during cell triggering requires intracellular granules. J Cell Physiol (1987) 0.92
Stimulation of human neutrophil adhesive properties by adenine nucleotides. J Immunol (1988) 0.92
Mediator release in an isolated airway segment in subjects with asthma. Am Rev Respir Dis (1988) 0.92
The cytoplasmic domain of FcgammaRIIA (CD32) participates in phagolysosome formation. Blood (2001) 0.91
Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils. J Immunol (2000) 0.91
Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood (1983) 0.91
Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood (1994) 0.90
Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines. J Interferon Cytokine Res (1996) 0.90
Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes. J Immunol (1999) 0.90
Prostatic adenocarcinoma, sarcoidosis and hypercalcemia: an unusual association. J Urol (1980) 0.90
Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. I. Search for target antigens in subcellular fractions. Cell Immunol (1975) 0.90
Thrombospondin production and thrombospondin-mediated adhesion in U937 cells. Exp Cell Res (1991) 0.90
Surface-bound immune complexes trigger transmembrane proximity between complement receptor type 3 and the neutrophil's cortical microfilaments. J Immunol (1992) 0.90
Novel molecular mechanisms of dendritic cell-induced T cell activation. Int Immunol (2000) 0.89
Intercellular adhesion molecule-1 in human corneal endothelium. Modulation and function. Am J Pathol (1991) 0.89
A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells. J Leukoc Biol (1998) 0.89
Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer. Science (1990) 0.89